VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
USA - NASDAQ:VMD - CA92663R1055 - Common Stock
6.49 USD
+0.1 (+1.56%)
VMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. VMD has an average financial health and profitability rating. VMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes VMD very considerable for growth investing!
1. Profitability
1.1 Basic Checks
VMD had positive earnings in the past year.
In the past year VMD had a positive cash flow from operations.
VMD had positive earnings in each of the past 5 years.
In the past 5 years VMD always reported a positive cash flow from operatings.
1.2 Ratios
VMD has a Return On Assets of 7.57%. This is amongst the best in the industry. VMD outperforms 90.00% of its industry peers.
Looking at the Return On Equity, with a value of 10.00%, VMD is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
VMD has a Return On Invested Capital of 7.91%. This is in the better half of the industry: VMD outperforms 73.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VMD is in line with the industry average of 9.40%.
The 3 year average ROIC (7.66%) for VMD is below the current ROIC(7.91%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROIC | 7.91% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
With a decent Profit Margin value of 5.80%, VMD is doing good in the industry, outperforming 80.00% of the companies in the same industry.
VMD's Profit Margin has declined in the last couple of years.
VMD has a better Operating Margin (6.82%) than 68.00% of its industry peers.
In the last couple of years the Operating Margin of VMD has declined.
VMD has a Gross Margin of 58.33%. This is in the better half of the industry: VMD outperforms 80.00% of its industry peers.
In the last couple of years the Gross Margin of VMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VMD is destroying value.
VMD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VMD has more shares outstanding
VMD has a better debt/assets ratio than last year.
2.2 Solvency
VMD has an Altman-Z score of 5.74. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
VMD has a better Altman-Z score (5.74) than 87.00% of its industry peers.
VMD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, VMD belongs to the top of the industry, outperforming 82.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.74 |
ROIC/WACC0.86
WACC9.21%
2.3 Liquidity
VMD has a Current Ratio of 1.48. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
VMD has a Current ratio (1.48) which is in line with its industry peers.
VMD has a Quick Ratio of 1.37. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.37, VMD perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.22% over the past year.
The Earnings Per Share has been growing slightly by 4.01% on average over the past years.
The Revenue has grown by 22.54% in the past year. This is a very strong growth!
The Revenue has been growing by 22.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
Revenue 1Y (TTM)22.54%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
3.2 Future
VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.89% yearly.
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.73% yearly.
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.67, the valuation of VMD can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of VMD indicates a somewhat cheap valuation: VMD is cheaper than 67.00% of the companies listed in the same industry.
VMD is valuated rather cheaply when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.25, which indicates a correct valuation of VMD.
Based on the Price/Forward Earnings ratio, VMD is valued a bit cheaper than 79.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, VMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.67 | ||
| Fwd PE | 13.25 |
4.2 Price Multiples
VMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VMD is cheaper than 91.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.43 |
4.3 Compensation for Growth
VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VMD may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)0.63
PEG (5Y)4.9
EPS Next 2Y32.27%
EPS Next 3Y24.89%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:VMD (11/17/2025, 10:49:59 AM)
6.49
+0.1 (+1.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners68.04%
Inst Owner ChangeN/A
Ins Owners13.25%
Ins Owner Change1%
Market Cap251.75M
Revenue(TTM)224.26M
Net Income(TTM)13.98M
Analysts80
Price Target13.94 (114.79%)
Short Float %1.14%
Short Ratio2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)6.08%
Min EPS beat(4)-5.7%
Max EPS beat(4)32.01%
EPS beat(8)1
Avg EPS beat(8)-11.48%
EPS beat(12)3
Avg EPS beat(12)-7.67%
EPS beat(16)4
Avg EPS beat(16)-7.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.49%
Revenue beat(8)5
Avg Revenue beat(8)-0.39%
Revenue beat(12)8
Avg Revenue beat(12)0.05%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)0%
PT rev (3m)5.13%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)-10%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)3.97%
Revenue NQ rev (3m)8.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.67 | ||
| Fwd PE | 13.25 | ||
| P/S | 1.05 | ||
| P/FCF | N/A | ||
| P/OCF | 5.88 | ||
| P/B | 1.8 | ||
| P/tB | 2.38 | ||
| EV/EBITDA | 5.43 |
EPS(TTM)0.33
EY5.08%
EPS(NY)0.49
Fwd EY7.55%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.1
OCFY17.02%
SpS6.21
BVpS3.6
TBVpS2.73
PEG (NY)0.63
PEG (5Y)4.9
Graham Number5.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROCE | 11.16% | ||
| ROIC | 7.91% | ||
| ROICexc | 9.15% | ||
| ROICexgc | 12.45% | ||
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% | ||
| FCFM | N/A |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexgc growth 3Y2.65%
ROICexgc growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.08 | ||
| Cap/Depr | 176.74% | ||
| Cap/Sales | 19.28% | ||
| Interest Coverage | 25.41 | ||
| Cash Conversion | 100.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 5.74 |
F-Score8
WACC9.21%
ROIC/WACC0.86
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)22.54%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y5.79%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year219.91%
EBIT Next 3Y63.61%
EBIT Next 5YN/A
FCF growth 1Y-132.43%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y26.82%
OCF growth 3Y20.23%
OCF growth 5Y15.41%
VIEMED HEALTHCARE INC / VMD FAQ
What is the ChartMill fundamental rating of VIEMED HEALTHCARE INC (VMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to VMD.
What is the valuation status for VMD stock?
ChartMill assigns a valuation rating of 6 / 10 to VIEMED HEALTHCARE INC (VMD). This can be considered as Fairly Valued.
Can you provide the profitability details for VIEMED HEALTHCARE INC?
VIEMED HEALTHCARE INC (VMD) has a profitability rating of 6 / 10.
What is the earnings growth outlook for VIEMED HEALTHCARE INC?
The Earnings per Share (EPS) of VIEMED HEALTHCARE INC (VMD) is expected to grow by 31.06% in the next year.